Capricor Therapeutics, Inc. (CAPR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.34B |
| Enterprise Value | 1.07B |
| P/E Ratio | -12.65 |
| PEG Ratio | 0.28 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 6.05 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 1.41 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.35 |
| Return On Equity | -0.59 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -100.11M |
| Net Income | -105.04M |
| Diluted EPS | -2.26 |
| Total Cash | 278.61M |
| Total Cash/Share | 4.85 |
| Total Debt | 21.12M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 8.42 |
| Book Value Per Share | 4.85 |
| 52-Week Change | 282.03 |
| 52-Week High | 40.37 |
| 52-Week Low | 4.3 |
| Moving Average 50 Days | 30.58 |
| Moving Average 200 Days | 21.38 |
| Average Volume | 1.04M |
| Shares Outstanding | 45.72M |
| % Held by Institutions | 69.24 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 05, 2019 |